Arvind N. Dasari
Impact in
- Oncology top 0.5%
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Surgical Treatments
- Epidemiology top 0.5%
- Neuroendocrine Tumor Research Advances
Papers in
- Oncology 82
- Colorectal Cancer Treatments and Studies 37
- Lung Cancer Research Studies 24
- Pancreatic and Hepatic Oncology Research 11
- Colorectal Cancer Surgical Treatments 10
- Epidemiology 62
- Neuroendocrine Tumor Research Advances 62
- Co-authors
- James C. Yao (27 shared papers)Daniel M. Halperin (27 shared papers)Chan Shen (12 shared papers)Ya‐Chen Tina Shih (9 shared papers)Shouhao Zhou (8 shared papers)Ying Hui Xu (7 shared papers)Bo Zhao (1 shared paper)Scott Kopetz (28 shared papers)
- Journals
- The Oncologist (10 papers)Clinical Colorectal Cancer (8 papers)Journal of Clinical Oncology (7 papers)Clinical Cancer Research (6 papers)Annals of Oncology (6 papers)
- Partner nations
- United StatesSpainCanada
In The Last Decade
Arvind N. Dasari
153 papers receiving 9.0k citations
Arvind N. Dasari's Hit Papers
Peers
Comparison fields: 5 of 133
- Oncology 4.6k
- Epidemiology 3.8k
- Neurology 1.6k
- Cancer Research 1.1k
- Pathology and Forensic Medicine 959
Countries citing papers authored by Arvind N. Dasari
This map shows the geographic impact of Arvind N. Dasari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arvind N. Dasari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arvind N. Dasari more than expected).
Fields of papers citing papers by Arvind N. Dasari
This network shows the impact of papers produced by Arvind N. Dasari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arvind N. Dasari. The network helps show where Arvind N. Dasari may publish in the future.
Co-authors
The 25 scholars most cited alongside Arvind N. Dasari, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 161 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States Hit paper breakdown → | 2017 | 2579 |
| 2 | Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF -Mutated Colorectal Cancer Hit paper breakdown → | 2015 | 593 |
| 3 | Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018 Hit paper breakdown → | 2019 | 425 |
| 4 | 2020 | 291 | |
| 5 | 2017 | 275 | |
| 6 | Epidemiology, Incidence, and Prevalence of Neuroendocrine Neoplasms: Are There Global Differences? Hit paper breakdown → | 2021 | 242 |
| 7 | 2017 | 235 | |
| 8 | 2012 | 230 | |
| 9 | Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study Hit paper breakdown → | 2023 | 219 |
| 10 | 2015 | 217 | |
| 11 | 2020 | 215 | |
| 12 | 2017 | 209 | |
| 13 | 2014 | 197 | |
| 14 | 2018 | 195 | |
| 15 | Neoadjuvant Pembrolizumab in Localized Microsatellite Instability High/Deficient Mismatch Repair Solid Tumors Hit paper breakdown → | 2023 | 144 |
| 16 | Survival improvement for patients with metastatic colorectal cancer over twenty years Hit paper breakdown → | 2023 | 121 |
| 17 | 2014 | 110 | |
| 18 | 2014 | 99 | |
| 19 | 2020 | 97 | |
| 20 | 2020 | 86 |
About Arvind N. Dasari
Arvind N. Dasari is a scholar working on Oncology, Epidemiology, Neurology, Cancer Research and Pathology and Forensic Medicine, having authored 161 papers that have together received 9.2k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (62 papers), Colorectal Cancer Treatments and Studies (37 papers), Lung Cancer Research Studies (24 papers), Neuroblastoma Research and Treatments (23 papers), Genetic factors in colorectal cancer (13 papers), Cancer Genomics and Diagnostics (12 papers), Pancreatic and Hepatic Oncology Research (11 papers) and Colorectal Cancer Surgical Treatments (10 papers). The work is most often cited by research in Oncology (4.6k citations), Epidemiology (3.8k citations), Neurology (1.6k citations), Cancer Research (1.1k citations) and Pathology and Forensic Medicine (959 citations). Arvind N. Dasari has collaborated with scholars based in United States, Spain and Canada. Frequent co-authors include James C. Yao, Daniel M. Halperin, Chan Shen, Ya‐Chen Tina Shih, Shouhao Zhou, Ying Hui Xu, Bo Zhao, Scott Kopetz, Satya Das and Michael James Overman. Their work appears in journals such as The Oncologist, Clinical Colorectal Cancer, Journal of Clinical Oncology, Clinical Cancer Research and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.